Signal Explorer
10-K · 10-Q · 8-K · last 6 months · ← back to feed
Clene Inc.
CLNN
Other
Form 8K Filing Disclosure
Core
Indication Expansion
Other
Ipo Net Proceeds Disclosure
Use Of Proceeds Disclosure
Other
Financing Activities Cash Flow Disclosure
Cash Flow Statement Investing Activities
Warrant Valued Black Scholes
Shares Outstanding Disclosure
Ipo Net Proceeds Disclosure
Publication Positive
Expanded Access Program Active
Net Loss Reported
Interim Data Positive
Pension Contribution Disclosure
Convertible Debt Conversion
Equity Plan Board Approval Conditional On Shareholder Vote
Weighted Average Interest Rate Disclosed
Core
Clinical Trial Result
Biotech Risk
Clinical Hold Active
Other
Equity Plan Board Approval Conditional On Shareholder Vote
Form 8K Filing Disclosure
Other
Financing Activities Cash Flow Disclosure
Ipo Net Proceeds Disclosure
Shares Outstanding Disclosure
Fast Track Granted
Warrant Valued Black Scholes
Orphan Status Granted
Fast Track Designation Received
Net Loss Reported
Pension Contribution Disclosure
Ipo Or Capital Raising Completion
Equity Compensation Accounting Policy
Debt Discount Amortization Disclosed
Breakthrough Therapy Granted
Core
Regulatory Designation Only
Biotech Risk
Orphan Drug Designation
Other
Form 8K Filing Disclosure
Director Continuity Stated
Other
Ipo Net Proceeds Disclosure
Use Of Proceeds Disclosure
Core
Regulatory Designation Only
Indication Expansion
Other
Fast Track Granted
Orphan Status Granted
Fast Track Designation Received
Breakthrough Therapy Granted
Rmat Designation Received
Biotech Risk
Orphan Drug Designation